S&P 500   4,538.43 (-0.84%)
DOW   34,580.08 (-0.17%)
QQQ   383.13 (-1.74%)
AAPL   161.84 (-1.17%)
MSFT   323.01 (-1.97%)
FB   306.84 (-1.14%)
GOOGL   2,840.03 (-0.67%)
AMZN   3,389.79 (-1.38%)
TSLA   1,014.97 (-6.42%)
NVDA   306.93 (-4.46%)
BABA   111.96 (-8.23%)
NIO   32.15 (-11.19%)
CGC   9.99 (-3.57%)
AMD   144.01 (-4.43%)
GE   92.77 (-2.58%)
MU   81.62 (-1.52%)
T   23.46 (+1.78%)
F   19.14 (-3.67%)
DIS   146.22 (-0.67%)
PFE   54.27 (+2.32%)
AMC   29.01 (-4.19%)
ACB   5.82 (-5.21%)
BA   198.49 (-1.92%)
S&P 500   4,538.43 (-0.84%)
DOW   34,580.08 (-0.17%)
QQQ   383.13 (-1.74%)
AAPL   161.84 (-1.17%)
MSFT   323.01 (-1.97%)
FB   306.84 (-1.14%)
GOOGL   2,840.03 (-0.67%)
AMZN   3,389.79 (-1.38%)
TSLA   1,014.97 (-6.42%)
NVDA   306.93 (-4.46%)
BABA   111.96 (-8.23%)
NIO   32.15 (-11.19%)
CGC   9.99 (-3.57%)
AMD   144.01 (-4.43%)
GE   92.77 (-2.58%)
MU   81.62 (-1.52%)
T   23.46 (+1.78%)
F   19.14 (-3.67%)
DIS   146.22 (-0.67%)
PFE   54.27 (+2.32%)
AMC   29.01 (-4.19%)
ACB   5.82 (-5.21%)
BA   198.49 (-1.92%)
S&P 500   4,538.43 (-0.84%)
DOW   34,580.08 (-0.17%)
QQQ   383.13 (-1.74%)
AAPL   161.84 (-1.17%)
MSFT   323.01 (-1.97%)
FB   306.84 (-1.14%)
GOOGL   2,840.03 (-0.67%)
AMZN   3,389.79 (-1.38%)
TSLA   1,014.97 (-6.42%)
NVDA   306.93 (-4.46%)
BABA   111.96 (-8.23%)
NIO   32.15 (-11.19%)
CGC   9.99 (-3.57%)
AMD   144.01 (-4.43%)
GE   92.77 (-2.58%)
MU   81.62 (-1.52%)
T   23.46 (+1.78%)
F   19.14 (-3.67%)
DIS   146.22 (-0.67%)
PFE   54.27 (+2.32%)
AMC   29.01 (-4.19%)
ACB   5.82 (-5.21%)
BA   198.49 (-1.92%)
S&P 500   4,538.43 (-0.84%)
DOW   34,580.08 (-0.17%)
QQQ   383.13 (-1.74%)
AAPL   161.84 (-1.17%)
MSFT   323.01 (-1.97%)
FB   306.84 (-1.14%)
GOOGL   2,840.03 (-0.67%)
AMZN   3,389.79 (-1.38%)
TSLA   1,014.97 (-6.42%)
NVDA   306.93 (-4.46%)
BABA   111.96 (-8.23%)
NIO   32.15 (-11.19%)
CGC   9.99 (-3.57%)
AMD   144.01 (-4.43%)
GE   92.77 (-2.58%)
MU   81.62 (-1.52%)
T   23.46 (+1.78%)
F   19.14 (-3.67%)
DIS   146.22 (-0.67%)
PFE   54.27 (+2.32%)
AMC   29.01 (-4.19%)
ACB   5.82 (-5.21%)
BA   198.49 (-1.92%)
NASDAQ:TRNS

Transcat Stock Forecast, Price & News

$88.00
-2.04 (-2.27%)
(As of 12/3/2021 12:00 AM ET)
Add
Compare
Today's Range
$86.13
$90.89
50-Day Range
$63.41
$98.80
52-Week Range
$32.05
$101.05
Volume
16,618 shs
Average Volume
35,643 shs
Market Capitalization
$661.67 million
P/E Ratio
57.14
Dividend Yield
N/A
Beta
0.76
30 days | 90 days | 365 days | Advanced Chart
Receive TRNS News and Ratings via Email

Sign-up to receive the latest news and ratings for Transcat and its competitors with MarketBeat's FREE daily newsletter.


Transcat logo

About Transcat

Transcat, Inc. engages in provision of calibration and laboratory instrument services. It operates through the Service and Distribution segments. The Service segment offers calibration, repair, inspection, analytical qualifications, preventive maintenance, consulting, and other related services. The Distribution segment distributes professional grade test, measurement, and control instrumentation. The company was founded in 1964 and is headquartered in Rochester, NY.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Instruments to measure electricity
Sub-Industry
N/A
Current Symbol
NASDAQ:TRNS
Employees
765
Year Founded
N/A

Sales & Book Value

Annual Sales
$173.34 million
Cash Flow
$1.93 per share
Book Value
$10.74 per share

Profitability

Net Income
$7.79 million
Pretax Margin
6.97%

Debt

Price-To-Earnings

Miscellaneous

Free Float
7,023,000
Market Cap
$661.67 million
Optionable
Not Optionable

Company Calendar

Last Earnings
11/02/2021
Today
12/03/2021
Next Earnings (Estimated)
2/01/2022
Fiscal Year End
3/31/2022

MarketRank

Overall MarketRank

2.26 out of 5 stars

Computer And Technology Sector

299th out of 890 stocks

Instruments To Measure Electricity Industry

4th out of 9 stocks

Analyst Opinion: 1.5Community Rank: 4.8Dividend Strength: 0.0Insider Behavior: 2.5Valuation: 2.5 5 -4 -3 -2 -1 -












Transcat (NASDAQ:TRNS) Frequently Asked Questions

Is Transcat a buy right now?

6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Transcat in the last year. There are currently 6 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Transcat stock.
View analyst ratings for Transcat
or view top-rated stocks.

How has Transcat's stock been impacted by COVID-19 (Coronavirus)?

Transcat's stock was trading at $27.83 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, TRNS shares have increased by 216.2% and is now trading at $88.00.
View which stocks have been most impacted by COVID-19
.

Are investors shorting Transcat?

Transcat saw a decrease in short interest in the month of November. As of November 15th, there was short interest totaling 79,300 shares, a decrease of 39.3% from the October 31st total of 130,700 shares. Based on an average daily volume of 32,400 shares, the days-to-cover ratio is currently 2.4 days. Currently, 1.2% of the company's shares are sold short.
View Transcat's Short Interest
.

When is Transcat's next earnings date?

Transcat is scheduled to release its next quarterly earnings announcement on Tuesday, February 1st 2022.
View our earnings forecast for Transcat
.

How were Transcat's earnings last quarter?

Transcat, Inc. (NASDAQ:TRNS) issued its quarterly earnings results on Tuesday, November, 2nd. The scientific and technical instruments company reported $0.40 EPS for the quarter, topping the consensus estimate of $0.37 by $0.03. The scientific and technical instruments company had revenue of $50.39 million for the quarter, compared to analyst estimates of $47.20 million. Transcat had a net margin of 6.11% and a trailing twelve-month return on equity of 15.31%. During the same quarter last year, the firm earned $0.27 earnings per share.
View Transcat's earnings history
.

What price target have analysts set for TRNS?

6 Wall Street analysts have issued 1 year price targets for Transcat's shares. Their forecasts range from $43.50 to $95.00. On average, they anticipate Transcat's stock price to reach $70.58 in the next year. This suggests that the stock has a possible downside of 19.8%.
View analysts' price targets for Transcat
or view top-rated stocks among Wall Street analysts.

Who are Transcat's key executives?

Transcat's management team includes the following people:
  • Lee D. Rudow, President, Chief Executive Officer & Director (LinkedIn Profile)
  • Leanne E. Branham, Vice President-Operations
  • Mark A. Doheny, Chief Financial Officer & Vice President-Finance
  • Andrew J. Quaranto, Vice President-Information Technology
  • Michael W. West, Vice President-Marketing & Distribution (LinkedIn Profile)

What is Lee Rudow's approval rating as Transcat's CEO?

20 employees have rated Transcat CEO Lee Rudow on Glassdoor.com. Lee Rudow has an approval rating of 69% among Transcat's employees.

What other stocks do shareholders of Transcat own?

What is Transcat's stock symbol?

Transcat trades on the NASDAQ under the ticker symbol "TRNS."

Who are Transcat's major shareholders?

Transcat's stock is owned by a variety of institutional and retail investors. Top institutional investors include Neuberger Berman Group LLC (10.92%), Wasatch Advisors Inc. (8.96%), BlackRock Inc. (5.80%), Dimensional Fund Advisors LP (3.02%), Victory Capital Management Inc. (2.09%) and Geode Capital Management LLC (1.65%). Company insiders that own Transcat stock include Carl E Sassano, Charles P Hadeed, Craig D Cairns, Gary J Haseley, Lee D Rudow, Lee D Rudow, Michael Tschiderer, Michael W West, Richard J Harrison and Scott Deverell.
View institutional ownership trends for Transcat
.

Which institutional investors are selling Transcat stock?

TRNS stock was sold by a variety of institutional investors in the last quarter, including Wasatch Advisors Inc., Minerva Advisors LLC, Two Sigma Advisers LP, Two Sigma Investments LP, Conestoga Capital Advisors LLC, California State Teachers Retirement System, Russell Investments Group Ltd., and Dimensional Fund Advisors LP. Company insiders that have sold Transcat company stock in the last year include Charles P Hadeed, Lee D Rudow, Michael W West, Richard J Harrison, and Scott Deverell.
View insider buying and selling activity for Transcat
or view top insider-selling stocks.

Which institutional investors are buying Transcat stock?

TRNS stock was acquired by a variety of institutional investors in the last quarter, including EAM Global Investors LLC, Neuberger Berman Group LLC, EAM Investors LLC, Victory Capital Management Inc., Summit Global Investments, Goldman Sachs Group Inc., Morgan Stanley, and BlackRock Inc.. Company insiders that have bought Transcat stock in the last two years include Craig D Cairns, Gary J Haseley, and Michael Tschiderer.
View insider buying and selling activity for Transcat
or or view top insider-buying stocks.

How do I buy shares of Transcat?

Shares of TRNS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Transcat's stock price today?

One share of TRNS stock can currently be purchased for approximately $88.00.

How much money does Transcat make?

Transcat has a market capitalization of $661.67 million and generates $173.34 million in revenue each year. The scientific and technical instruments company earns $7.79 million in net income (profit) each year or $1.54 on an earnings per share basis.

How many employees does Transcat have?

Transcat employs 765 workers across the globe.

What is Transcat's official website?

The official website for Transcat is www.transcat.com.

Where are Transcat's headquarters?

Transcat is headquartered at 35 VANTAGE POINT DRIVE, ROCHESTER NY, 14624.

How can I contact Transcat?

Transcat's mailing address is 35 VANTAGE POINT DRIVE, ROCHESTER NY, 14624. The scientific and technical instruments company can be reached via phone at (585) 352-7777, via email at [email protected], or via fax at 585-352-1486.


This page was last updated on 12/3/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.